Sequence features accurately predict genome-wide MeCP2 binding in vivo
- PMID: 27008915
- PMCID: PMC4820824
- DOI: 10.1038/ncomms11025
Sequence features accurately predict genome-wide MeCP2 binding in vivo
Abstract
Methyl-CpG binding protein 2 (MeCP2) is critical for proper brain development and expressed at near-histone levels in neurons, but the mechanism of its genomic localization remains poorly understood. Using high-resolution MeCP2-binding data, we show that DNA sequence features alone can predict binding with 88% accuracy. Integrating MeCP2 binding and DNA methylation in a probabilistic graphical model, we demonstrate that previously reported genome-wide association with methylation is in part due to MeCP2's affinity to GC-rich chromatin, a result replicated using published data. Furthermore, MeCP2 co-localizes with nucleosomes. Finally, MeCP2 binding downstream of promoters correlates with increased expression in Mecp2-deficient neurons.
Figures





References
-
- Amir R. E. et al.. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185–188 (1999). - PubMed
-
- Van den Veyver I. B. & Zoghbi H. Y. Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr. Opin. Genet. Dev. 10, 275–279 (2000). - PubMed
-
- Lewis J. D. et al.. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905–914 (1992). - PubMed
-
- Chandler S. P., Guschin D., Landsberger N. & Wolffe A. P. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38, 7008–7018 (1999). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases